Sign up to save your podcasts
Or
Share The complement system in NMOSD and MG: A target for therapeutic benefit?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The complement system in NMOSD and MG: A target for therapeutic benefit?
touchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
To view this activity in full and to access the downloadable materials please visit: touchOPHTHALMOLOGY
View all episodes
By touchpodcasttouchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
- Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
To view this activity in full and to access the downloadable materials please visit: touchOPHTHALMOLOGY